The shares outstanding are 103.50M, and float is at 86.67M with Short Float at 34.18%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Clover Health Investments Corp. (NASDAQ: CLOV) is -56.23% lower on its value in year-to-date trading and has touched a low of $6.31 and a high of $17.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLOV stock was last observed hovering at around $7.59 in the last trading session, with the day’s loss setting it -0.25% off its average median price target of $14.00 for the next 12 months. It is also 51.07% off the consensus price target high of $15.00 offered by 4 analysts, but current levels are 26.6% higher than the price target low of $10.00 for the same period.
Currently trading at $7.34, the stock is -12.31% and -32.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.54 million and changing -3.29% at the moment leaves the stock -34.41% off its SMA200. CLOV registered a loss of -38.73% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $9.55 and a 200-day simple moving average (SMA200) of $11.39.
The stock witnessed a -21.91% gain in the last 1 month and extending the period to 3 months gives it a -50.74%, and is -16.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.54% over the week and 10.16% over the month.
Distance from 52-week low is 16.32% and -57.94% from its 52-week high.
Clover Health Investments Corp. (CLOV) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Clover Health Investments Corp. (CLOV) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 2.00, where 2 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Clover Health Investments Corp. is expected to release its quarterly report on 06/02/2021 and quarterly earnings per share for the current quarter are estimated at -$0.84 with sales reaching $166.23M over the same period..